Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 37

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 37
---
 successful. See “Cautionary Note Regarding Forward-Looking Statements.”

There are no assurances that the Extension will enable us to complete a business combination.

Approving the Extension involves
a number of risks. Even if the Extension is approved and implemented, the Company can provide no assurances that the Business Combination
will be consummated prior to the Extended Date. Our ability to consummate any business combination is dependent on a variety of factors,
many of which are beyond our control. If the Extension is approved and implemented, the Company intends to seek shareholder approval of
the Business Combination and consummate the Business Combination. We are required to offer shareholders the opportunity to redeem their
public shares in connection with the M&A Amendment Proposals and, if needed, any additional amendments to the M&A, and we will
be required to offer shareholders redemption rights again in connection with any shareholder vote to approve an initial business combination.
Even if the M&A Amendment Proposals (or the Business Combination) are approved by our shareholders, it is possible that redemptions
will leave us with insufficient cash to consummate an initial business combination on commercially acceptable terms, or at all. The fact
that we will have separate redemption periods in connection with the Extension and the Business Combination vote could exacerbate these
risks. Other than in connection with a redemption offer or liquidation, our shareholders may be unable to recover their investment except
through sales of our shares on the open market. The price of our shares may be volatile, and there can be no assurance that shareholders
will be able to dispose of our shares at favorable prices, or at all.

We may not be able to complete an initial business combination with certain potential target companies if a proposed transaction with the target company is subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.

Our sponsor is an Australian
proprietary limited company. Jiang Hui Bao, a non-U.S. person, is the Chief Executive Officer of our Sponsor. In addition, the members
of the Sponsor are non-U.S. persons. The level of control and ownership of the Sponsor may prevent us from completing an initial business
combination with certain U.S. targets as described below.

Certain acquisitions or an
initial business combination may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or
regulations. In the event that such regulatory approval or clearance is not obtained, or the review process is extended beyond the period
of time that would